Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
After mesothelioma is diagnosed, the next step is to try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.
The stages of mesothelioma range from I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And within a stage, an earlier letter (after the number) means a lower stage. Each person with cancer is unique, but cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
Pleural mesothelioma (malignant pleural mesothelioma or MPM), the most common type, is the only mesothelioma that has a formal staging system. These mesotheliomas start in the pleura, which includes the lining of the lungs and the inner lining of the chest wall.
The staging system most often used for MPM is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 3 key pieces of information:
Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced. Once a person’s T, N, and M categories have been determined, this information is combined in a process called stage grouping to assign an overall stage. For more on this, see Cancer Staging.
The system described below is the most recent AJCC system, effective as of January 2018. It's used only for malignant pleural mesotheliomas. Mesotheliomas starting in other places are less common and do not have formal staging systems.
MPM typically is given a clinical stage based on the results of a physical exam, biopsy, and imaging tests (as described in How Is Malignant Mesothelioma Diagnosed?). If surgery is done, the pathologic stage (also called the surgical stage) is determined by examining the tissue removed during the operation.
Cancer staging can be complex, so ask your doctor to explain it to you in a way you understand.
AJCC Stage |
Stage grouping |
Stage description* |
IA |
T1 N0 M0 |
Mesothelioma is in the pleura lining the chest wall on one side of the chest. It may or may not also affect the pleura lining the diaphragm (the thin breathing muscle below the lungs), the mediastinum (the space between the lungs), or the pleura covering the lung (T1). It has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
IB |
T2 N0 M0 |
Mesothelioma is in the pleura lining the chest wall on one side of the chest, as well as in the pleura coating the diaphragm, the mediastinum, and the lung. It also has grown into the diaphragm or the lung itself (T2). It has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
T3 N0 M0 |
Mesothelioma has grown into nearby structures but may still possibly be removed (resected) with surgery (T3). The tumor is in the pleura lining the chest wall on one side of the chest, as well as the pleura coating the lung, the diaphragm, and the mediastinum on the same side. It also has grown into at least 1 of the following:
The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
|
II |
T1 or T2 N1 M0 |
Mesothelioma is in the pleura lining the chest wall on one side of the chest (T1), and it may have grown into the diaphragm or the lung itself (T2). The cancer has spread to nearby lymph nodes on the same side of the body as the main tumor (N1). It has not spread to distant parts of the body (M0). |
IIIA |
T3 N1 M0 |
Mesothelioma has grown into nearby structures but may still possibly be removed (resected) with surgery (T3). The tumor is in the pleura lining the chest wall on one side of the chest, as well as the pleura coating the lung, the diaphragm, and the mediastinum on the same side. It also has grown into at least 1 of the following:
The cancer has spread to nearby lymph nodes on the same side of the body as the main tumor (N1). It has not spread to distant parts of the body (M0). |
IIIB
|
T1-T3 N2 M0 |
Mesothelioma may or may not have grown into nearby structures, and it may still possibly be removed (resected) with surgery (T1 to T3). The cancer has spread to nearby lymph nodes on the other side of the body, or to lymph nodes above the collarbone (supraclavicular lymph nodes) on either side (N2). It has not spread to distant parts of the body (M0). |
OR |
||
T4 Any N M0 |
Mesothelioma has grown too far to be removed completely with surgery (T4). The tumor is in the pleura lining the chest wall on one side of the chest, as well as the pleura coating the lung, diaphragm, and mediastinum on the same side. The tumor also has grown into at least 1 of the following:
The cancer may or may not have spread to nearby lymph nodes (any N). It has not spread to distant parts of the body (M0). |
|
IV |
Any T Any N M1 |
Mesothelioma may or may not have grown into nearby structures (any T). It may or may not have spread to nearby lymph nodes (any N). It has spread to distant organs, like the bones, the liver, the lung or pleura on the other side of the body, or the peritoneum (the lining of the abdomen) (M1). |
* The following categories may be used, but are not listed on the table above:
The TNM system groups mesotheliomas into stages that help give doctors an idea about a person’s prognosis (outlook). But for treatment purposes, doctors often use a simpler system, based on whether the cancer is likely to be resectable (where all visible tumor can be removed by surgery) or unresectable (all of the cancer cannot be removed).
In general, most stage I and II mesotheliomas, as well as some stage III, might be resectable, but there are exceptions. Whether the cancer can be removed depends not only on how far the tumor has grown, but also on its subtype (most doctors believe only epithelioid and mixed/biphasic tumors are potentially resectable), where it’s located, and if the patient is healthy enough to have surgery.
Even for resectable mesotheliomas, in most cases cancer cells that can’t be seen are left behind after surgery. Because of this, many doctors use other treatments (radiation therapy and/or chemotherapy) along with surgery when possible.
Stage is an important factor in predicting a person’s prognosis (outlook), but other factors also play a role. Some factors linked to longer survival times include:
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
American Joint Committee on Cancer. Malignant Pleural Mesothelioma. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 457-468.
Pass HI, Carbone M, Krung LM, Rosenzweig KE. Chapter 114: Benign and malignant mesothelioma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.
Rusch VW, Giroux D, Kennedy C, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7(11):1631-1639.
Last Revised: November 16, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.